EWTX Edgewise Therapeutics, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
17:40
Jun 28
Jun 28
Author increased their ABVX position as a concentrated conviction bet on Obe commercialization at ~$8B market cap, while closing COGT and BCRX for decent returns, and notes XBI outperformance as a positive sector signal.
LOW
00:00
Jun 24
Jun 24
Author explicitly closed EWTX position; listed under "Closed" in weekly portfolio update despite remaining constructive on the story longer-term.
MED
12:00
Jun 16
Jun 16
SpaceX rises 7.3% in premarket, Mag 7 stocks are mixed, Domo drops 13% on strategic review, Edgewise falls 23% on trial results, Edwards Lifesciences gains 3.1% on coverage proposal, Huntsman drops 7% on merger with Olin, and Robinhood gains 2% on workforce reduction.
18:11
Jun 12
Jun 12
Hold/long EWTX; author retains position despite mixed sentiment post-Seva news, dismisses afib concern as overstated, and sees CV exposure making it a BP acquisition target — though conviction is lower than other holdings.
MED
21:57
Jun 06
Jun 06
Author is holding EWTX into an imminent data readout (n=7500 dataset expected this month) that could serve as a near-term price catalyst; considered selling but chose to maintain position.
MED
12:36
Jun 01
Jun 01
Buy EWTX — author discloses an ongoing long position, citing a better-than-expected Seva deal that exceeded their valuation estimates, leaving EWTX as a cleaner, focused cardio pure-play.
MED
18:19
May 19
May 19
Author adds to ABVX and NKTR positions ahead of key data, expressing bullish conviction on ABVX's high probability of meeting endpoints while holding other biotech names for later review.
HIGH
17:44
May 07
May 07
Long EWTX, a biotech holding with conviction from the speaker's due diligence.
HIGH
16:41
May 05
May 05
Seedy19 expresses a personal preference for EWtx over another ticker, indicating a bullish directional view on EWtx.
HIGH
16:35
May 05
May 05
Re-enter long $EWTX as part of a cardiovascular-biotech pair, citing overdue exposure and a current buying opportunity.
HIGH
About EWTX Analyst Coverage
Buzzberg tracks EWTX (Edgewise Therapeutics, Inc.) across 2 sources. 6 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (60%). 10 total trade ideas tracked. Latest voices: seedy19tron, zerohedge.